Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia.

Autor: Gurieva, Oksana Dmitryevna, Savelyeva, Marina Ivanovna, Valiev, Timur Tejmurazovich, Sozaeva, Zhannet Alimovna, Kondratenko, Svetlana Nikolaevna, Ilyin, Mikhail Vitalyevich

Publikováno v: Drug Metabolism & Personalized Therapy; Dec2023, Vol. 38 Issue 4, p349-357, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Study of the pharmacokinetics of various drugs under conditions of antiorthostatic hypokinesia and the pharmacokinetics of acetaminophen under long-term spaceflight conditions.

Autor: Polyakov, Alexey V., Svistunov, Andrey A., Kondratenko, Svetlana N., Kovachevich, Irina V., Repenkova, Lyudmila G., Savelyeva, Marina I., Shikh, Evgenia V., Badriddinova, Lidiya Y.

Publikováno v: Drug Metabolism & Personalized Therapy; Jun2022, Vol. 37 Issue 2, p163-175, 13p

The particulars of certain drugs' effect on the endogenous coenzyme Q10 plasma level in patients with cardiovascular diseases.

Autor: Shikh, Evgenia, Zozina, Vladlena, Kondratenko, Svetlana, Melnikov, Evgeny, Kukes, Vladimir

Publikováno v: Drug Metabolism & Personalized Therapy; Jun2020, Vol. 35 Issue 2, p1-6, 6p

Study of the pharmacokinetics of various drugs under conditions of antiorthostatic hypokinesia and the pharmacokinetics of acetaminophen under long-term spaceflight conditions.

Autor: Polyakov AV; Laboratory for the Development of Means and Methods of Medical Care in Extreme Conditions and Telemedicine of the State Scientific Centre of the Russian Federation, Institute of Medical and Biological Problems of the Russian Academy of Sciences, Moscow, Russian Federation., Svistunov AA; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation., Kondratenko SN; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation., Kovachevich IV; Laboratory for the Development of Means and Methods of Medical Care in Extreme Conditions and Telemedicine of the State Scientific Centre of the Russian Federation, Institute of Medical and Biological Problems of the Russian Academy of Sciences, Moscow, Russian Federation., Repenkova LG; Laboratory for the Development of Means and Methods of Medical Care in Extreme Conditions and Telemedicine of the State Scientific Centre of the Russian Federation, Institute of Medical and Biological Problems of the Russian Academy of Sciences, Moscow, Russian Federation., Savelyeva MI; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russian Federation., Shikh EV; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation., Badriddinova LY; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russian Federation.

Publikováno v: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2021 Nov 29. Date of Electronic Publication: 2021 Nov 29.